JILL SNIDER: Open Payments
NPI 1427227883 · WYTHEVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 32 payments from 15 companies in 2025. Trend: 2023 $1,529 · 2024 $1,893 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $112 |
| Novo Nordisk Inc | 4 | $74 |
| PFIZER INC. | 4 | $70 |
| Exact Sciences Corporation | 3 | $65 |
| ABBVIE INC. | 3 | $56 |
| Abbott Laboratories | 2 | $48 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Insulet Corporation | 1 | $31 |
| Lilly USA, LLC | 1 | $30 |
Products named: Cologuard Collection Kit, AIRSUPRA, Ozempic, FREESTYLE LIBRE 3, INSPIRE, QULIPTA, NEXLETOL, BREZTRI.
Industry payments across VA — which companies pay providers there.
